Loading
OP
Ohr Pharmaceutical Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Symetryx Corp, was filed 07 Sept 2023.
Ohr Pharmaceutical Inc: what insiders have been doing
Ohr Pharmaceutical Inc is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Ohr Pharmaceutical Inc has published a filing in the past twelve months. The most recent one dates from 18 September 2023.
The full history, which starts in 2016, counts 128 purchases against 6 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
149
Thresholds
n/a
Buy Volume
€1M
128 ops. · all time
Sell Volume
€667,574
6 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended September 2022 · cache
Income statement
Net income-US$29.2M
Last declaration on 18 September 2023
Declarations149 total
103,337 shares@ US$1.2616.9% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000005:1
50,000 shares@ US$1.197.7% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000005:2
129,108 shares@ US$1.4449.1% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000005:0
128,847 shares@ US$1.5325.5% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000003:1
3,376 shares@ US$1.440.6% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000003:2
74,852 shares@ US$1.8035.4% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000003:0
61,076 shares@ US$0.97815.5% of flowCommon Stock, Par Value $0.0001 per ShareSEC:0001991925-23-000002:0
Canonical exit: 30 Nov 2023 (T+90)
93,234 shares@ US$0.02267.9% of flowCommon StockSEC:0001104659-23-087887:0
54,200 shares0Common stockSEC:0001104659-23-033858:0
153,000 shares0Common stockSEC:0001104659-23-033856:0
655,000 shares0Common StockSEC:0001104659-23-022495:0
750,000 shares@ US$0.001130.8% of flowCommon StockSEC:0001104659-22-104744:0
6,200 shares@ US$1.92100.0% of flowCommon stockSEC:0001104659-22-041749:0
Canonical exit: 28 Jun 2022 (T+90)
10,000 shares@ US$1.8152.5% of flowCommon stockSEC:0001104659-22-036105:0
Canonical exit: 16 Jun 2022 (T+90)
10,000 shares@ US$1.7433.7% of flowCommon stockSEC:0001104659-22-035572:1
Canonical exit: 15 Jun 2022 (T+90)
10,000 shares@ US$1.6247.5% of flowCommon stockSEC:0001104659-22-035572:0
Canonical exit: 14 Jun 2022 (T+90)
1,300 shares@ US$1.722.3% of flowCommon stockSEC:0001104659-22-031172:1
Canonical exit: 1 Jun 2022 (T+90)
1,000 shares@ US$1.621.7% of flowCommon stockSEC:0001104659-22-031172:2
Canonical exit: 2 Jun 2022 (T+90)
1,580 shares@ US$1.58100.0% of flowCommon stockSEC:0001104659-22-031172:0
Canonical exit: 30 May 2022 (T+90)
42,250 shares@ US$0.0011.4% of flowCommon StockSEC:0001104659-22-001691:0
8,000 shares@ US$4.75100.0% of flowCommon StockSEC:0001104659-21-083253:0
Canonical exit: 16 Sept 2021 (T+90)
5,000 shares@ US$5.0025.1% of flowCommon stockSEC:0001104659-21-055582:0
Canonical exit: 25 Jul 2021 (T+90)
12,000 shares@ US$5.0039.7% of flowCommon StockSEC:0001104659-21-055581:0
Canonical exit: 25 Jul 2021 (T+90)
12,000 shares@ US$5.0036.4% of flowCommon StockSEC:0001104659-21-055580:0
Canonical exit: 25 Jul 2021 (T+90)
5,000 shares@ US$5.0066.0% of flowCommon StockSEC:0001104659-21-055578:0
Canonical exit: 25 Jul 2021 (T+90)
25 of 149 declarations
About Ohr Pharmaceutical Inc
Ohr Pharmaceutical Inc is a biopharmaceutical company focused on developing treatments for eye diseases. The company is listed on NASDAQ under the ticker OHRP.
